Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report;Impiego del fattore VII attivato ricombinante (rFVIIa-NovoSeven) nel trattamento di una emorragia post-chirurgica incontrollabile e di filtro cavale. Un caso clinico

Minerva Anestesiologica

Volumn 72, Issue 7-8, 2006, Pages 675-682

  Marson, F ^a   Farnia, A ^a   Callegher, L ^a   Casagrande, L ^a   Surdu, M ^a   Sarpellon, M ^a  

^a ULSS 9   (Italy)

Author keywords

Hemorrhage; Hemostasis; Kidney transplantation; Recombinant activated factor VII; Venous thrombosis

Indexed keywords

HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ANEMIA; ARTICLE; CADAVER DONOR; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL PROTOCOL; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFERIOR CAVA VEIN; KIDNEY TRANSPLANTATION; PERITONEAL DIALYSIS; PLASMA TRANSFUSION; POSTOPERATIVE HEMORRHAGE; SURGICAL TECHNIQUE; THROMBOCYTE TRANSFUSION; VENA CAVA FILTER;

ADULT; FACTOR VIIA; FEMALE; HEMOSTATICS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; VENA CAVA FILTERS; VENOUS THROMBOSIS;

EID: 33747418951     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hedner H, Erhardtsen E. Potential role for rFVIIa in transfusive medicine. Transfusion 2002;42:114-24.
2. Murkin JM. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice. Can J Anesth 2002;49:S21-S26.
3. Grounds M. Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review. Blood Rev 2003;17:S11-S21.
4. Allen GA, Hoffman M, Roberts HR, Monroe DM. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage. Can J Anesth 2002;49:S7-S14.
5. Erhardtsen E. Ongoing NovoSeven trials. Intensive Care Med 2000;28:S248-S255.
6. Midathada MV, Mehta P, Waner M, Fink LM. Recombinant factor VIIa in the treatment of bleeding. Am J Clin Pathol 2004;121:124-37.
7. Aledort LM. rFVIIa - its thrombogenicity. Thromb Haemost 2000;84:522-3.
8. Peerlinck K, Vermylen J. Acute myocardial infarction following administration of recombinant activated factor VII (NovoSeven) in a patient with haemophilia A and inhibitor. Tromb Haemost 1999;82:1775-6.
9. d'Orion R, Ménart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M et al. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. Thromb Haemost 2000;83:644-7.
10. Worth LL, Hoots WK. Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII deficient infant. Haemophilia 1998;4:757-61.
11. Van der Planken MG, Schroyens W, Vertessen F, Michiels JJ, Berneman ZN. Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion. Blood Coagul Fibrinolys 2002;13:367-70.
12. Brown JL, Varma S, Morgan-Hughes NJ, Rocco G. Thrombosis related to emergency factor VIIa treatment. Anaesthesia 2003;58:1245.
13. Pavese P, Bonadona A, Beaubien J, Labrecque P, Pernod G, Letoublon C et al. VIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Can J Anaesth 2005;52:26-9.
14. Ng HJ, Loh SM, Tan DC, Lee LH. Thrombosis associated with the use of recombinant activated factor VII: profiling two events. Thromb Haemost 2004;92:1448-9.
15. Roberts HA. Recombinant factor VIIa (NovoSeven) and the safety of treatment. Semin Hematol 2001;38 (Suppl 12):48-50.
16. Hedner U. NovoSeven as a universal haemostatic agent. Blood Coagul Fibrinol 2000;11(Suppl 1):S107-S111.
17. Moscardo F, Perez F, de la Rubia J, Balordi B, Lorenzo JI, Senent ML et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001;114:174-6.
18. Key NS. Recombinant FVIIa for intractable hemorrhage: more questions than answers (editorial). Transfusion 2003;43:1649-51.
19. Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. Can J Anesth 2002;49:S15-S20.
20. Bui JD, Despotis GD, Trulock EP, Patterson GA, Goodnough LT. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg 2002;124:852-4.
21. Zietkiewicz M, Garlicky M, Domagala J, Wierzbicki K, Drwila R, Pfitzner R et al. Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device. J Thorac Cardiovasc Surg 2002;123:384-5.
22. Potapov EV, Pasic M, Bauer M, Hetzer R. Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device. Ann Thor Surg 2002;74:2182-3.
23. Martinowitz U, Holcomb JB, Pusateri AE, Macaitis JM, Hedner U, Hess JR. Intravenous rFVIIa administred for hemorrhage control in hypothermic coagulopathic swine grade V liver injuries. J Trauma 2001;50:721-9.
24. Lynn M, Jeroukhimov I, Jewelewicz D, Popkin C, Johnson EW, Rashid QN et al. Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: a pilot study. J Trauma 2002;52:703-7.
25. Schreiber A, Holcomb J, Hedner U, Brundage S, Macaitis J, Hoots K. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries. J Trauma 2002;53:252-9.
26. Hoffman M, Monroe DM, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinol 1998;9:61-5.
27. Moisescu E, Ardelean L, Simion I, Murescan A, Ciupan R. Recombinant factor VIIa treatment of bleeding associated with acute renal failure. Blood Coagul Fibrinol 2000;11:575-7.
28. Dunkley SM, Mackie F. Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent. Hematology 2003;8:263-4.